IFNG and rheumatoid arthritis: The polymorphism did not affect plasma IFN-γ levels among symptomatic patients when they were assessed according to the clinical presentation of the disease or in the presence of the enhanced inflammatory process involving the nervous tissue and joints, as observed among patients with HAM/TSP and rheumatoid arthritis.